Characteristics of Disseminated Her2+ Breast Cancer Patients Treated With Trastuzumab That Have Reached Complete, Partial Remission or Stabilization of Disease During More Than 3 Years
Status: COMPLETED
Study type: OBSERVATIONAL
Conditions: HER-2 Positive Breast Cancer
Sponsor: Asociación para el Progreso de la Oncología en Málaga
Collaborators: Roche Farma, S.A